OssDsign

medical devices

About

OssDsign is a Swedish medtech company based in Uppsala, specializing in orthobiologics products that enhance the body's natural bone healing processes. Founded in 2011 through a collaboration between Uppsala University and Karolinska University, OssDsign shifted its focus to orthobiologics in January 2024, moving away from its initial emphasis on cranial implants. The company's flagship product, OssDsign Catalyst, is a nanosynthetic bone graft putty designed for spinal fusion surgeries. It promotes rapid bone formation by engaging dual bone formation pathways and is the first synthetic bone graft cleared for interbody use based solely on bone graft data. OssDsign Catalyst is characterized by its scalability and high gross margins, and the company is actively conducting clinical studies to support its efficacy. With around 50 employees, OssDsign was listed on the Nasdaq First North Growth Market in Stockholm in 2019.

Technologies

NetSuite Outlook Microsoft Office 365 Cision Bootstrap Framework Mobile Friendly Multilingual Circle Remote

Keywords

medical devices bone regeneration bonegraft orthopaedic surgery spine surgery orthobiologics orthopedic products nanosynthetic bone graft interbody fusion bone formation pathways bone fusion technology spinal interbody cages bone graft clearance orthopedic surgery bone healing in avascular environments intramembranous pathway clinical evidence regenerative medicine clinical surgeon testimonials orthopedic devices bone graft data regulatory compliance regulatory approval surgical products dual bone formation pathways spinal fusion product development medical device development bone healing technology ionic amplification

Location

2 Virdings alle, Uppsala, Uppsala County, Sweden, 754 50

Related Companies

Companies in the same industry